natgillin/translations-raw huggingface dataset:
For these situations, in order to provide for a safe transition towards freedom from disease under favourable epidemiological conditions, Member States should be allowed to demarcate a ‘provisionally free area’ subject to the condition that monitoring and surveillance to ascertain the absence of virus circulation is carried out.
V teh primerih bi bilo treba za varen prehod v stanje brez bolezni v ugodnih epidemioloških razmerah državam članicam omogočiti razmejitev „območja, začasno prostega bolezni“, pod pogojem, da se izvajata spremljanje in nadzor za zagotovitev, da virus ne kroži več.
According to the Scientific Opinion of the Panel on Animal Health and Welfare of the EFSA on the ‘Risk of Bluetongue Transmission in Animal Transit’, adopted on 11 September 2008 [5], there is a theoretical possibility that infectious midges co-travel with the animals.
Glede na znanstveno mnenje Sveta za zdravje in zaščito živali agencije EFSA o tveganju za prenos bolezni modrikastega jezika pri tranzitu živali (Risk of Bluetongue Transmission in Animal Transit), sprejeto 11. septembra 2008 [5], je teoretično možno, da se skupaj z živalmi prenašajo tudi okužene mušice.
That risk might be controlled by cleaning the vehicle and treating it with insecticides or repellents before loading the animals or when moving animals through areas known to be at low risk or at a period of time when the risk is known to be low.
Navedeno tveganje je mogoče nadzirati tako, da se vozilo pred natovarjanjem živali očisti in obdela z insekticidi ali repelenti, ali tako, da se živali prepelje prek območij z nizkim tveganjem ali v obdobju, ko je tveganje nizko.
In order to limit undesired effects to the environment of those substances and to avoid possible problems as regards waiting periods and possible residues in the animals, the treatment of animals with authorised insecticides or repellents should no longer be required as this treatment provides for limited additional safety.
Zaradi omejevanja neželenih učinkov teh snovi na okolje in preprečevanja mogočih težav, povezanih s čakalnimi dobami, ter morebitnih ostankov teh snovi v živalih uporaba odobrenih insekticidov ali repelentov na živalih ne bi več smela biti potrebna, saj zagotavlja zgolj omejeno dodatno varnost.
Regulation (EC) No 1266/2007, as amended by Implementing Regulation (EU) No 648/2011 [6], allows, for a transitional period, Member States of destination, in which the introduction of non-immune animals under certain circumstances could pose a risk for animal health, to require that the movement of such animals is subject to certain additional conditions.
Uredba (ES) št. 1266/2007, kot je bila spremenjena z Izvedbeno uredbo Komisije (EU) št. 648/2011 [6], dovoljuje namembnim državam članicam, v katerih bi vstop neimunih živali v določenih okoliščinah lahko pomenil tveganje za zdravje živali, da v prehodnem obdobju za premik takih živali zahtevajo določene dodatne pogoje.
As rules on criteria for vector protected establishments are laid down in this Regulation, that transitional provision is no longer necessary.
Ker so merila za obrate z zaščito pred vektorji določena v tej uredbi, navedena prehodna določba ni več potrebna.
Due to the different levels of virus circulation, environmental conditions and different vaccination strategies in the Member States, the epidemiological situations as regards bluetongue may differ considerably in different areas of the Union.
Zaradi različnih stopenj kroženja virusa, okoljskih razmer in različnih strategij cepljenja v državah članicah se lahko epidemiološko stanje pri bolezni modrikastega jezika na različnih območjih Unije precej razlikuje.
Experience has shown that different surveillance strategies may be successfully implemented to achieve the desired objectives.
Izkušnje kažejo, da se lahko za doseganje želenih ciljev uspešno uvedejo različne strategije nadzora.
Therefore, the minimum harmonised requirements for monitoring and surveillance as laid down in Annex I to Regulation (EC) No 1266/2007 should be simplified to allow for more flexibility for the Member States to design their national monitoring and surveillance programmes, taking into account the Scientific Opinion of the EFSA Panel on Animal Health and Welfare on bluetongue monitoring and surveillance [7].
Zato bi bilo treba poenostaviti minimalne usklajene zahteve za spremljanje in nadzor iz Priloge I k Uredbi (ES) št. 1266/2007, ki bi državam članicam omogočale več prožnosti pri oblikovanju njihovih nacionalnih programov spremljanja in nadzora, pri čemer bi se upoštevalo znanstveno mnenje Sveta za zdravje in zaščito živali agencije EFSA v zvezi s spremljanjem in nadzorom bolezni modrikastega jezika [7].
Based on the abovementioned Scientific Opinion, the minimum sample size to detect a prevalence of 5 % with 95 % confidence in the susceptible species population should be sufficient for surveillance for the purpose of demonstrating the absence of virus circulation in an epidemiological relevant geographical area during a period of two years.
Na podlagi zgoraj navedenega znanstvenega mnenja bi moral biti za ugotavljanje 5-odstotne razširjenosti s 95-odstotno gotovostjo v populaciji dovzetnih živali pri nadzoru dovolj minimalen vzorec, da se na epidemiološko pomembnem geografskem območju dokaže odsotnost kroženja virusa v obdobju dveh let.
Keeping bluetongue susceptible animals in a vector proof establishment for a specified period of time is an important requirement for certain conditions for exemptions from the exit ban as set out in Annex III to Regulation (EC) No 1266/2007.
Pomembna zahteva pri nekaterih pogojih za izvzetje iz prepovedi izstopa, ki so določeni v Prilogi III k Uredbi (ES) št. 1266/2007, je namestitev živali, dovzetnih za bolezen modrikastega jezika, v obratih z dokazano zaščito pred vektorji za določen čas.
Experience shows that it is difficult for Member States to establish proper criteria for the implementation of a vector proof establishment for regular movements for trade in animals of susceptible species such as cattle, sheep and goats.
Izkušnje kažejo, da je državam članicam težko določiti ustrezna merila za uvedbo obratov z dokazano zaščito pred vektorji zaradi rednih premikov dovzetnih vrst živali, na primer goveda, ovc in koz, za namene trgovanja.
In order to improve the effectiveness of vector proof establishments and to assist the Member States in their implementation of that control measure, a number of criteria should be established.
Zaradi izboljšanja učinkovitosti obratov z dokazano zaščito pred vektorji in zagotavljanja pomoči državam članicam pri izvajanju navedenega nadzornega ukrepa bi bilo treba določiti številna merila.
Those criteria should be based on experiences of the Member States and the Terrestrial Animal Health Code of the World Organisation for Animal Health (OIE).
Ta merila bi morala temeljiti na izkušnjah držav članic in Zoosanitarnem kodeksu za kopenske živali Mednarodne organizacije za zdravje živali (OIE).
To align the terminology with the OIE, the term ‘vector proof establishment’, currently used in Regulation (EC) No 1266/2007, should be replaced by ‘vector protected establishment’.
Zaradi uskladitve terminologije z OIE bi bilo treba izraz „obrat z dokazano zaščito pred vektorji“, ki se trenutno uporablja v Uredbi (ES) št. 1266/2007, zamenjati z izrazom „obrat z zaščito pred vektorji“.
In response to new scientific information which indicates the possibility of transplacental transmission of the bluetongue virus, in particular for bluetongue virus serotype 8, precautionary measures to prevent the possible spread of bluetongue by pregnant animals or certain newborn animals were introduced in Regulation (EC) No 1266/2007, as amended by Regulation (EC) No 384/2008 [8].
Ob upoštevanju novih znanstvenih dognanj, po katerih bi se lahko virus bolezni modrikastega jezika, še zlasti virus serotipa 8, prenašal prek placente, so bili z Uredbo (ES) št. 1266/2007, kot je bila spremenjena z Uredbo (ES) št. 384/2008 [8], uvedeni previdnostni ukrepi za preprečevanje morebitnega širjenja bolezni modrikastega jezika prek brejih živali ali nekaterih novorojenih živali.
In the light of the conclusions of that opinion, the precautionary measure as regards the movement of pregnant animals should only apply for zones which are restricted for bluetongue virus serotype 8.
Ob upoštevanju sklepov navedenega mnenja bi bilo treba previdnostne ukrepe za premik brejih živali uporabljati le na območjih z omejitvami glede virusa bolezni modrikastega jezika serotipa 8.
Regulation (EC) No 1266/2007 should therefore be amended accordingly.
Uredbo (ES) št. 1266/2007 bi bilo zato treba ustrezno spremeniti.
Member States shall implement bluetongue monitoring and surveillance programmes in accordance with the minimum requirements set out in Annex I.’;
Države članice izvajajo programe spremljanja in nadzora bolezni modrikastega jezika v skladu z minimalnimi zahtevami iz Priloge I.“
in Article 6, paragraph 2 is replaced by the following:
V členu 6 se odstavek 2 nadomesti z naslednjim:
Before taking any decision to remove an epidemiologically relevant geographical area from a restricted zone, Member States shall provide the Commission with substantiated information demonstrating the absence of bluetongue virus circulation in that area during a period of two years, including two full vector activity seasons, following the implementation of the bluetongue monitoring and surveillance programme in accordance with point 3 of Annex I.’;
Pred sprejetjem kakršne koli odločitve o umiku epidemiološko pomembnega geografskega območja z območja z omejitvami države članice Komisiji predložijo utemeljene podatke o tem, da virus bolezni modrikastega jezika dve leti po začetku izvajanja programa spremljanja in nadzora bolezni modrikastega jezika v skladu s točko 3 Priloge I, vključno s celotnima sezonama aktivnosti vektorja, na navedenem območju ne kroži več.“
in Article 7, paragraph 2a is replaced by the following:
V členu 7 se odstavek 2a nadomesti z naslednjim:
Member States may demarcate an epidemiological relevant geographical area in a restricted zone as a “provisionally free area” provided that for a period of one year, including one full vector season, monitoring and surveillance in accordance with point 3 of Annex I has demonstrated the absence of bluetongue virus circulation in that part of the restricted zone for that specific bluetongue serotype or combination of serotypes.
Države članice lahko razmejijo epidemiološko pomembno geografsko območje na območju z omejitvami kot „območje, začasno prosto bolezni“, če virus bolezni modrikastega jezika navedenega serotipa ali kombinacije serotipov po podatkih spremljanja in nadzora v skladu s točko 3 Priloge I v navedenem delu območja z omejitvami eno leto, vključno s celotno sezono vektorja, ni krožil.
A Member State which intends to demarcate a restricted zone or part of a restricted zone as a “provisionally free area” shall notify its intention to the Commission.
Država članica, ki namerava razmejiti območje z omejitvami ali del območja z omejitvami kot „območje, začasno prosto bolezni“, o tem obvesti Komisijo.
That notification shall be accompanied by the information referred to in point 3 of Annex I.
Navedenemu obvestilu priloži podatke iz točke 3 Priloge I.
The Commission shall inform the Member States in the framework of the Standing Committee on the Food Chain and Animal Health of the list of “provisionally free areas”.
Komisija državam članicam v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali sporoči seznam „območij, začasno prostih bolezni“.
Movements of animals within the same restricted zone from an area where the same bluetongue virus serotype or serotypes are circulating to a part of the same restricted zone demarcated as a “provisionally free area” may only be permitted if:
Premiki živali znotraj istega območja z omejitvami, in sicer iz dela, na katerem kroži isti serotip ali serotipi virusa bolezni modrikastega jezika, v del istega območja z omejitvami, ki je razmejeno kot „območje, začasno prosto bolezni“, se dovolijo le:
the animals comply with the conditions set out in Annex III; or
če živali ustrezajo pogojem iz Priloge III, ali
the animals comply with any other appropriate animal health guarantees based on a positive outcome of a risk assessment of measures against the spread of the bluetongue virus and protection against attacks by vectors, required by the competent authority of the place of origin and approved by the competent authority of the place of destination, prior to the movement of such animals; or
če so izpolnjena katera koli druga ustrezna jamstva za zdravstveno varstvo živali na podlagi pozitivnega rezultata ocene tveganja ukrepov proti širjenju virusa bolezni modrikastega jezika in zaščite pred napadi vektorjev, ki jih zahteva pristojni organ kraja izvora ter odobri pristojni organ namembnega kraja pred premikom teh živali, ali
the animals are destined for immediate slaughter.’;
če so živali namenjene takojšnjemu zakolu.“
in Article 8(5), the third subparagraph is replaced by the following:
V členu 8(5) se tretji pododstavek nadomesti z naslednjim:
‘Information on the designated slaughterhouses shall be made available to the other Member States and to the public.’;
„Podatki o izbranih klavnicah se dajo na voljo drugim državam članicam in javnosti.“
after adequate cleansing and disinfection at the place of loading, the means in which the animals are transported are treated with authorised insecticides and/or repellents.
se po ustreznem čiščenju in dezinfekciji na kraju natovarjanja sredstva za prevoz živali obdelajo z odobrenimi insekticidi in/ali repelenti.
This treatment must in any case take place prior to leaving or entering the restricted zone;
Prevozno sredstvo mora biti obdelano pred zapustitvijo območja z omejitvami oziroma pred vstopom vanj;
when a rest period of more than one day is foreseen at a control post during the movement through a restricted zone, the animals are protected against attacks by vectors in a vector protected establishment in accordance with the criteria set out in Annex II.
so živali pred napadi vektorjev zaščitene v obratu z zaščito pred vektorji v skladu z merili iz Priloge II, ko je pri prevozu skozi območje z omejitvami predviden več kot en dan počitka na kontrolni točki.
Paragraph 1 shall not apply if the transit takes place:
Odstavek 1 se ne uporablja, če tranzit poteka:
exclusively from or through epidemiologically relevant geographical areas of the restricted zone during the bluetongue seasonally vector-free period defined in accordance with Annex V; or
izključno z epidemiološko pomembnih geografskih območij območja z omejitvami ali prek njih med sezono brez vektorjev za bolezen modrikastega jezika, opredeljeno v skladu s Prilogo V, ali
from or through parts of the restricted zone demarcated as a “provisionally free area” in accordance with Article 7(2a).
iz delov območja z omejitvami, razmejenega kot „območje, začasno prosto bolezni“, v skladu s členom 7(2a), ali prek njih.
For the animals referred to in paragraph 1 of this Article, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC: “Insecticide/repellent treatment with … (insert name of the product) on … (insert date) in conformity with Article 9 of Regulation (EC) No 1266/2007.”’;
Za živali iz odstavka 1 tega člena se ustreznim zdravstvenim spričevalom iz direktiv 64/432/EGS, 91/68/EGS in 92/65/EGS ali iz Odločbe 93/444/EGS doda naslednje besedilo: ‚Tretiranje z insekticidi/repelenti … (vstaviti ime proizvoda) dne … (vstaviti datum) v skladu s členom 9 Uredbe (ES) št. 1266/2007.‘ “
Article 9a is deleted;
Člen 9a se črta.
Annexes I, II, III and V are amended in accordance with the Annex to this Regulation.
Priloge I, II, III in V se spremenijo v skladu s Prilogo k tej uredbi.
Done at Brussels, 30 May 2012.
V Bruslju, 30. maja 2012
EFSA Journal 2011; 9(6): 2192.
The EFSA Journal (2011), 9(6): 2192.
EFSA Journal 2011; 9(5): 2189.
EFSA Journal (2011), 9(5): 2189.
Annexes I, II, III and V to Regulation (EC) No 1266/2007 are amended as follows:
Priloge I, II, III in V k Uredbi (ES) št. 1266/2007 se spremenijo:
Bluetongue monitoring and surveillance programmes shall be aimed at;
Namen programov spremljanja in nadzora bolezni modrikastega jezika je:
detecting any possible incursions of the bluetongue virus and;
odkrivanje morebitnega vnosa virusa bolezni modrikastega jezika in
where appropriate, demonstrating the absence of certain serotypes of that virus in a Member State or epidemiologically relevant geographical area; or
dokazovanje odsotnosti nekaterih serotipov navedenega virusa v državi članici ali na epidemiološko pomembnem geografskem območju, kjer je to primerno, ali
determining the seasonally vector free period (entomological surveillance).
določanje sezone brez vektorjev (entomološki nadzor).
The geographical unit of reference for the purposes of bluetongue monitoring and surveillance shall be defined by a grid of around 45 x 45 km (approximately 2000 km2) unless specific environmental conditions justify a different size.
Referenčna geografska enota za namene spremljanja in nadzora bolezni modrikastega jezika se določi z mrežo velikosti približno 45 × 45 km (približno 2000 km2), razen če posebne okoljske razmere upravičujejo drugačno velikost.
If appropriate, Member States may also use the “region” as defined in Article 2.2(p) of Directive 64/432/EEC or the regions as defined in Annex X to Commission Decision 2005/176/EC of 1 March 2005 laying down the codified form and the codes for the notification of animal diseases pursuant to Council Directive 82/894/EEC as the geographical unit of reference for monitoring and surveillance purposes.2.
Če je ustrezno, lahko države članice kot referenčno geografsko enoto za spremljanje in nadzor uporabijo tudi izraz ‚regija‘, kot je opredeljen v členu 2.2(p) Direktive 64/432/EGS, ali regije iz Priloge X k Odločbi Komisije 2005/176/ES z dne 1. marca 2005 o kodificirani obliki in kodah za prijavljanje živalskih bolezni v skladu z Direktivo Sveta 82/894/EGS.2.
Bluetongue monitoring and surveillance programmes aimed at detecting any possible incursions of the bluetongue virus
Programi za spremljanje in nadzor bolezni modrikastega jezika, namenjeni odkrivanju morebitnega vnosa virusa bolezni modrikastega jezika
Bluetongue monitoring and surveillance programmes aimed at detecting any possible incursions of the bluetongue virus shall consist of at least passive clinical surveillance and active laboratory-based surveillance.
Programi za spremljanje in nadzor bolezni modrikastega jezika, namenjeni odkrivanju morebitnega vnosa virusa bolezni modrikastega jezika, vključujejo vsaj pasivni klinični nadzor in aktivni laboratorijski nadzor.
Passive clinical surveillance shall consist of a formal and properly documented ongoing system aimed at detecting and investigating any suspicions, including an early warning system for reporting suspicions.
Pasivni klinični nadzor vključuje uradni in ustrezno dokumentiran stalni sistem, namenjen odkrivanju in preiskovanju kakršnih koli sumov, vključno s sistemom za zgodnje opozarjanje na poročila o sumih.
Active laboratory-based surveillance shall consist of an annual programme of at least one, or a combination of, serological/virological monitoring with sentinel animals, serological/virological surveys, or targeted monitoring and surveillance based on a risk assessment.
Aktivni laboratorijski nadzor vključuje letni program, ki zajema vsaj enega od naslednjih ukrepov, in sicer serološko/virološko spremljanje s kontrolnimi živalmi, serološke/virološke raziskave ali ciljno spremljanje in nadzor, ki temeljita na oceni tveganja.
Sampling may take place at pre-defined intervals throughout the year but shall at least be carried out once a year performed in the period of the year when infection or seroconversion is most likely to be detected.
Vzorčenje lahko poteka v vnaprej določenih intervalih skozi vse leto, vendar mora vsaj enkrat letno potekati v tistem obdobju leta, ko je odkritje okužbe ali serokonverzije najverjetnejše.
The bluetongue monitoring and surveillance programmes must be designed in such a way that the samples are taken from susceptible animals (that is animals which have not been vaccinated and which have been exposed to the competent vector), which are representative for the structure of the susceptible species population in the epidemiologically relevant geographical area.
Programi spremljanja in nadzora morajo biti zasnovani tako, da se vzorci odvzamejo dovzetnim živalim (živalim, ki niso bile cepljene in ki so bile izpostavljene primernemu vektorju), reprezentativnim glede na strukturo populacije dovzetnih vrst na epidemiološko pomembnem geografskem območju.
The sample size must be calculated to detect the appropriate design prevalence based on the known risk of the target population with 95 % confidence in the susceptible species population of that epidemiologically relevant geographical area.
Velikost vzorca je treba izračunati tako, da se na podlagi znanega tveganja ciljne populacije ugotovi ustrezna vzorčna razširjenost s 95-odstotno gotovostjo v populaciji dovzetnih vrst na navedenem epidemiološko pomembnem geografskem območju.
In the absence of scientific information on the expected prevalence for the target population the sample size must be calculated to detect a prevalence of 20 %.
Če znanstveni podatki o pričakovani razširjenosti v ciljni populaciji niso na voljo, je treba velikost vzorca izračunati tako, da se ugotovi 20-odstotna razširjenost.
Whenever the samples do not originate from individual animals, the sample size must be adjusted according to the sensitivity of the diagnostic procedures applied.
Kadar vzorci ne izvirajo iz posameznih živali, je treba velikost vzorca prilagoditi skladno z občutljivostjo uporabljenih diagnostičnih postopkov.
Laboratory-based surveillance shall be designed in such a way that positive screening tests are followed by the specific serotype serological/virological tests targeted to the bluetongue serotype or serotypes expected to be present in the epidemiologically relevant geographical area necessary to ascertain the specific serotype circulating.
Laboratorijski nadzor je zasnovan tako, da pozitivnim presejalnim testom sledijo serološki/virološki testi za posebne serotipe, namenjeni potrditvi serotipa ali serotipov virusa bolezni modrikastega jezika, katerih prisotnost na epidemiološko pomembnem geografskem območju je pričakovana, in potrebni za potrditev kroženja posebnega serotipa.
Bluetongue monitoring and surveillance programmes aimed at demonstrating the absence of certain serotypes of the bluetongue virus in a Member State or epidemiologically relevant geographical area
Programi za spremljanje in nadzor, namenjeni dokazovanju odsotnosti nekaterih serotipov virusa bolezni modrikastega jezika v državi članici ali na epidemiološko pomembnem geografskem območju
Bluetongue monitoring and surveillance programmes aimed at the demonstration of the absence of bluetongue virus circulation must comply with the conditions set out in points 2.1 and 2.2.
Programi spremljanja in nadzora, ki so namenjeni dokazovanju odsotnosti kroženja virusa bolezni modrikastega jezika, morajo izpolnjevati pogoje iz točk 2.1 in 2.2.
The sample size used for the active laboratory-based surveillance must be calculated to detect a prevalence of 5 % with 95 % confidence.
Velikost vzorca za aktivni laboratorijski nadzor je treba izračunati tako, da se s 95-odstotno gotovostjo ugotovi 5-odstotna razširjenost.
In addition: (a) for the purpose of removing an epidemiologically relevant geographical area from a restricted zone as referred to in Article 6(2), Member States must demonstrate the absence of bluetongue virus circulation during a period of at least two years, including two seasons of vector activity;
Poleg tega: (a) mora država članica za namene umika epidemiološko pomembnega geografskega območja iz območja z omejitvami iz člena 6(2) dokazati, da virus bolezni modrikastega jezika vsaj dve leti, vključno z dvema sezonama aktivnosti vektorja, ne kroži več.